Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL5201380

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CCN(Cc1ccccc1)C[C@@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C

Basic Information

ChEMBL ID CHEMBL5201380
Phase Preclinical
Structure Type MOL
InChI Key LEXXIHVLYCLEQC-KEZOAJOQSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names

Molecular Properties

429.6
MW (Da)
3.66
ALogP
4
HBA
2
HBD
55.8
PSA (Ų)
0.66
QED
0
Ro5 Violations
8
Rot. Bonds

Drug Information

Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C26H43N3O2
MW 429.65
Aromatic Rings 1
Heavy Atoms 31
NP-Likeness -0.74

Activity Summary

IC50 1 meas. best 5.38

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
IC50 5.38 5.38 4200.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked IC50 = 4200.0 nM 5.38 Inhibition of glycoprotein in luciferase expressing pseudotyped Ebola virus infe... 35872393

Literature References

PubMed DOI Target Context # Activities
35872393 10.1016/j.ejmech.2022.114608 Unchecked 2
35872393 10.1016/j.ejmech.2022.114608 Huh-7 1
35872393 10.1016/j.ejmech.2022.114608 ADMET 1

Data from ChEMBL 36 via Core Engine